The glycogen synthase kinase (GSK) 3β represses RNA polymerase I transcription

Oncogene

Volumn 27, Issue 39, 2008, Pages 5254-5259

  Vincent, T ^a   Kukalev, A ^a   Andang M ^a   Pettersson, R ^a   Percipalle, P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cell proliferation; GSK ; Pol I transcription; PTEN; rDNA; Tumour suppressors

Indexed keywords

DNA DIRECTED RNA POLYMERASE; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RIBOSOME DNA; RNA 18S; RNA 28S;

ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMATIN IMMUNOPRECIPITATION; ENDOTHELIUM CELL; EPITHELIUM CELL; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA SYNTHESIS;

CELL NUCLEOLUS; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOGEN SYNTHASE KINASE 3; MUTATION; PTEN PHOSPHOHYDROLASE; RNA POLYMERASE I; TRANSCRIPTION, GENETIC;

EID: 51349089480     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.152     Document Type: Article

References (25)

1. Al-Khouri AM, Ma Y, Togo SH, Williams S, Mustelin T. (2005). Cooperative phosphorylation of the tumour suppressor phopsphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3β. J Biol Chem 280: 35195-35196.
2. Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N et al. (1997). Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci USA 94: 861-866.
3. Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM. (2005). Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 168: 29-33.
4. Baker SJ. (2007). PTEN enters the nuclear age. Cell 128: 25-28.
5. Bijur GN, Jope RS. (2003). Glycogen synthase kinase 3β is highly activated in nuclei and mitochondria. Neurochemistry 14: 2415-2419.
6. Chu EC, Tarnawski AS. (2004). PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit 10: RA235-RA241.
7. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. (1998). PTEN is essential for embryonic development and tumor suppression. Nat Gen 19: 348-355.
8. Dominguez I, Itoh K, Sokol SY. (1995). Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. Proc Natl Acad Sci USA 92: 8498-8502.
9. Grummt I. (2003). Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev 17: 1691-1702.
10. Janda E, Lehman K, Killish I, Jechlinger M, Herzig M, Downward J et al. (2002). Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 156: 299-313.
11. Jope RS, Johnson GVW. (2004). The glamour and gloom of glycogen synthase-3. Trends Biochem Sci 29: 95-102.
12. Leslie NR, Downes CP. (2004). PTEN function: how normal cells control it and tumor cells lose it. Biochem J 382: 1-11.
13. Ma C, Wang J, Gao Y, Gao TW, Chen G, Bower KA et al. (2007). The role of glycogen synthase kinase 3beta in the transformation of epidermal cells. Cancer Res 67: 7756-7764.
14. Mayer C, Grummt I. (2004). Cellular stress and nucleolar function. Cell Cycle 4: 1036-1038.
15. Meijer L, Skaltsounis AL, Magiatis P, Polychronopoulos P, Knockaert M, Leost M et al. (2006). GSK-3-selective inhibitors derived from tyrian purple indirubins. Chem Biol 10: 1255-1266.
16. Morisco C, Zebrowski D, Condorelli G, Tsichlis P, Vatner SF, Sadoshima J. (2000). The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes. J Biol Chem275: 14466-14475.
17. Percipalle P, Fomproix N, Cavellan E, Voit R, Reimer G, Kruger T et al. (2006). The chromatin remodelling complex WSTF-SNF2h interacts with nuclear myosin 1 and has a role in RNA polymerase I transcription. EMBO rep 7: 525-530.
18. Salas TR, Reddy SA, Clifford JL, Davis RJ, Kikuchi A, Lippman SM et al. (2003). Alleviating the suppression of glycogen synthase kinase 3β by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei. J Biol Chem 278: 41338-41346.
19. Savino TM, Bastos R, Jansen E, Hernandez-Verdun D. (1999). The nucleolar antigen Nop52, the human homologue of the yeast ribosomal RNA processing RRP1, is recruited at late stages of nucleologenesis. J Cell Sci 112: 1889-1900.
20. Seither P, Grummt I. (1996). Molecular cloning of RPA2, the gene encoding the second largest subunit of mouse RNA polymerase I. Genomics 3: 135-139.
21. Torres J, Pulido R. (2001). The tumour suppressor PTEN is phosphorylated by the protein kinase CKII at its C-terminus. Implications for PTEN stability to proteasome-mediated degradation. J Biol Chem 276: 993-998..
22. Tseng A-S, Engel FB, Keating MT. (2006). The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem Biol 13: 957-963.
23. Wang Q, Zhou Y, Wang X, Evers BM. (2006). Glycogen synthase kinase 3 is a negative regulator of extracellular signal-regulated kinase. Oncogene 25: 43-50.
24. White RJ. (2005). RNA polymerases I and III growth control and cancer. Nat Rev Mol Cell Biol 6: 69-78.
25. Zhang C, Comai L, Johnson DL. (2005). PTEN Represses RNA polymerase I transcription by disrupting the SL1 complex. Mol Cell Biol 25: 6899-6911.